Payers worldwide are struggling with a new generation of precision medicines that come with a hefty price tag. Ben Hargreaves finds that the UK’s NICE is once again caught between ensuring ...
Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback